WuXi Advanced Therapies is an integrated Contract Testing Development and Manufacturing Organization (CTDMO) that is dedicated to transforming the discovery, development, manufacturing, and commercialization of biopharmaceuticals. With a focus on cell and gene therapies, they offer a comprehensive range of products and services. Their manufacturing capabilities include commercial and clinical manufacturing for cell and gene therapies, with expertise in AAV vector suspension, lentiviral vector, closed process CAR-T products, plasmid manufacturing, and viral products.

They also provide testing services such as analytical development, cell line characterization, materials characterization, and viral clearance validation. WuXi Advanced Therapies is committed to accelerating progress and time to market for biopharmaceuticals. With their integrated CTDMO approach, they ensure seamless collaboration between development and manufacturing, enabling faster and more efficient processes.

Based in Philadelphia, PA, WuXi Advanced Therapies is impacting lives around the world. Their dedication to innovation and expertise in cell and gene therapies make them a trusted partner for those looking to accelerate success in this field. Contact them today to speak to a technical expert and learn more about their technologies